Deacon, R.M.J

Regional dissociations within the hippocampus-memory and anxiety

Bannerman, D. M., Rawlins, J. N. P., McHugh, S. B., Deacon, R. M. J., Yee, B. K., Bast, T., Zhang, W.-N., Pothuizen, H. H. J., & Feldon, J. (2004) · Neuroscience & Biobehavioral Reviews

Memory and Neural MechanismsMemory Processes and Influences

Cited by 1,462

Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease.

Cunningham, C., Campion, S., Lunnon, K., Murray, C. L., Woods, J. F. C., Deacon, R. M. J., Rawlins, J. N. P., & Perry, V. H. (2009) · Biological Psychiatry

Prion Diseases and Protein MisfoldingNeuroinflammation and Neurodegeneration Mechanisms

Cited by 584

Ventral hippocampal lesions affect anxiety but not spatial learning

Bannerman, D. M., Grubb, M., Deacon, R. M. J., Yee, B. K., Feldon, J., & Rawlins, J. N. P. (2003) · Behavioural Brain Research

Memory and Neural MechanismsStress Responses and Cortisol

Cited by 530

Digging and marble burying in mice: simple methods for in vivo identification of biological impacts

Deacon, R. M. J. (2006) · Nature Protocols

Neurotransmitter Receptor Influence on BehaviorAnimal Behavior and Welfare Studies

Cited by 508

Human endogenous retrovirus glycoprotein–mediated induction of redox reactants causes oligodendrocyte death and demyelination

Antony, J. M., van Marle, G., Opii, W., Butterfield, D. A., Mallet, F., Yong, V. W., Wallace, J. L., Deacon, R. M., Warren, K., & Power, C. (2004) · Nature Neuroscience

Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms

Cited by 388

Housing, husbandry and handling of rodents for behavioral experiments

Deacon, R. M. J. (2006) · Nature Protocols

Animal Behavior and Welfare StudiesAnimal testing and alternatives

Cited by 246

Maternal neuronal antibodies associated with autism and a language disorder

Dalton, P., Deacon, R., Blamire, A., Pike, M., McKinlay, I., Stein, J., Styles, P., & Vincent, A. (2003) · Annals of Neurology

Autism Spectrum Disorder ResearchAutoimmune Neurological Disorders and Treatments

Cited by 204

NNZ-2566, a novel analog of (1–3) IGF-1, as a potential therapeutic agent for fragile X syndrome

Deacon, R. M. J., Glass, L., Snape, M., Hurley, M. J., Altimiras, F. J., Biekofsky, R. R., & Cogram, P. (2015) · NeuroMolecular Medicine

Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research

Cited by 78

Multiple behavior phenotypes of the fragile-X syndrome mouse model respond to chronic inhibition of phosphodiesterase-4D (PDE4D)

Gurney, M. E., Cogram, P., Deacon, R. M., Rex, C., & Tranfaglia, M. (2017) · Scientific Reports

Genetics and Neurodevelopmental DisordersPhosphodiesterase function and regulation

Cited by 69

Inhibition of peripheral TNF can block the malaise associated with CNS inflammatory diseases

Jiang, Y., Deacon, R., Anthony, D. C., & Campbell, S. J. (2008) · Neurobiology of Disease

Tryptophan and brain disordersNeuroinflammation and Neurodegeneration Mechanisms

Cited by 64

Effects of the sigma-1 receptor agonist blarcamesine in a murine model of fragile X syndrome: neurobehavioral phenotypes and receptor occupancy

Reyes, S. T., Deacon, R. M. J., Guo, S. G., Altimiras, F. J., Castillo, J. B., van der Wildt, B., Morales, A. P., Park, J. H., Klamer, D., Rosenberg, J., et al. (2021) · Scientific Reports

Genetics and Neurodevelopmental DisordersPharmacological Receptor Mechanisms and Effects

Cited by 22